Opinion: Empty Nest syndrome grips elderly in southern Indian state
By Aparna S March 26, 2024: With a high literacy rate, the migration rates in India’s southern state of Kerala have always been.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
By Aparna S March 26, 2024: With a high literacy rate, the migration rates in India’s southern state of Kerala have always been.
HQ Team March 25, 2024: Novo Nordisk, one of the world’s most valuable companies, will acquire Germany-based Cardior Pharmaceuticals, a firm that specialises.
HQ Team March 22, 2024: A recent study titled “Cryptic diversity of cellulose-degrading gut bacteria in industrialized humans” says that urban dwellers are.
HQ Team March 21, 2024: Richard Slayman, 62, of Weymouth, Massachusetts, became the first human to receive a kidney from a genetically modified.
HQ Team March 21, 2024: An abnormal protein called phosphorylated α-synuclein present in the nerve fibres in the skin — the pathological hallmark.
HQ Team March 21, 2024: Noland Arbaugh, 29, the first human to receive Neuralink’s brain implant, was able to play online chess and.
HQ Team March 21, 2024: A panel consisting of Nobel laureates, former presidents and prime ministers have urged global negotiators of WHO member.
HQ Team March 20, 2024: Bristol Myers Squibb, a New Jersey-based drugmaker, announced it has met its primary goal of improved overall survival.
HQ Team March 20, 2024: The Covid-19 virus can damage the heart, even without directly affecting the heart tissue, according to a study.
HQ Team March 20, 2024: The first dosing in a late-stage trial to evaluate an investigational drug for tuberculosis (TB) has started in.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)